NSE Indices to remove Infinium Pharmachem from Nifty SME Emerge from November 30
NSE has announced that Infinium Pharmachem will be removed from the Nifty SME Emerge index effective November 30. The change follows the exchange’s regular review of index constituents based on factors such as market capitalisation, liquidity and free‑float criteria.
The removal matters because many passive funds and ETFs track the Nifty SME Emerge index. When a stock drops out, those funds typically sell the shares, which can reduce trading volumes and put short‑term pressure on the price. Visibility among retail investors who follow the index may also decline.
Investors should watch how the stock reacts in the days after the delisting, any statements from the company about inclusion in other indices, and the broader fundamentals such as earnings and product pipeline. Changes in institutional holdings could also signal how the market is adjusting to the index change.
Affected stocks
Neutral1 stockBull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.
Key takeaways
- Concerns Infinium Pharmachem (INFINIUM).
- Category: Sector.
Why it matters
A routine update for Infinium Pharmachem. Use the price and stock snapshot to gauge how the market is responding.












